DocGo Inc. — Director's Dealing 2022

Dec 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DocGo Inc. (DCGO)
CIK: 0001822359
Period of Report: 2022-09-16

Reporting Person: TRAVERS JAMES M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-16	Common Stock	A	99019	—	Acquired	523159	Indirect
2022-11-04	Common Stock	D	7131	$0.00	Disposed	516028	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-16	Warrants to purchase Common Stock	$11.5	M	443432	Disposed	2026-12-05	Common Stock (99019)	Indirect

Footnotes

F1: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior Issuer's redemption of warrants, Travers Holdings LLC exercised its 443,432 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement.

F2: Securities are held by Travers Holdings LLC. Mr. Travers and Susan D. Travers are the managers of Travers Holdings and have shared voting and dispositive power over the securities of Issuer held by Travers Holdings. Mr. Travers and Susan D. Travers each disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.

F3: Pursuant to Section 3.2(c)(i) of the Stock Escrow Agreement, dated August 15, 2021, by and among Issuer, Motion Acquisition LLC, and Continental Stock Transfer & Trust Company (as assigned from time to time), on November 4, 2022, Travers Holdings LLC forfeited 7,131 shares of Common Stock for no consideration.